Netspot (GA-68 dotatate) unit dose X4
Ended Awarded Last action
- Contract number
- N0025921F0022
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $14,000
Award facts
- Contract value 100% obligated
- $14,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Millburn, NJ 07041, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $14,000 |
About this award
The Defense Health Agency awarded a $14,000 firm fixed-price blanket purchase agreement (BPA) call to Advanced Accelerator Applications USA Inc. for NETSPOT (gallium Ga 68 dotatate) unit doses on January 8, 2021, with completion targeted for March 17, 2021. This contract was issued without a small business set-aside designation and is being performed in Millburn, New Jersey. NETSPOT is a specialized radiopharmaceutical product used in diagnostic nuclear medicine imaging for various cancers, including neuroendocrine tumors. Advanced Accelerator Applications USA Inc., a foreign-owned subsidiary of Novartis, is a premier supplier of radiopharmaceutical products to federal healthcare systems and has maintained an active federal contracting presence since 2004.
This delivery order call draws from one of the company's larger indefinite delivery vehicle framework agreements with federal agencies under the Pharmaceuticals and Drugs Federal Supply Schedule. The vendor supplies critical nuclear medicine products across multiple federal healthcare entities, including the Department of Veterans Affairs, Defense Health Agency medical centers, and the National Institutes of Health Clinical Center. The company serves as a prime contractor with no identified subcontractors, providing direct supply of these specialized radiopharmaceutical products to support diagnostic and therapeutic capabilities across the federal healthcare system. Advanced Accelerator Applications USA Inc. maintains multiple BPAs and indefinite delivery contracts with cumulative values exceeding $100 million for various radiopharmaceutical products.
Quick answers
Who was awarded contract N0025921F0022?
N0025921F0022 was awarded to Advanced Accelerator Applications USA Inc. by Bureau of Medicine and Surgery (Department of the Navy) on January 8, 2021.
How much is contract N0025921F0022 worth?
The government has obligated $14,000 on N0025921F0022.
Which agency awarded contract N0025921F0022?
Bureau of Medicine and Surgery (Department of the Navy) awarded N0025921F0022, with funding from Defense Health Agency (Department of Defense).
Is contract N0025921F0022 an order under another contract?
Yes. N0025921F0022 is a BPA call under N0025920A0002, a blanket purchase agreement.
Was contract N0025921F0022 competed?
The extent of competition for N0025921F0022 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award